Navigation Links
ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
Date:8/27/2007

ImmuneRegen and TGen Continue Testing Possible Treatment for Acute Radiation Syndrome or Radiotherapy Adjuvant Likely Targeting Adult Stem

Cells in Bone Marrow

SCOTTSDALE, Ariz., Aug. 27 /PRNewswire-FirstCall/ -- ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTC Bulletin Board: IRBO), today announced that initial studies at TD2 (TGen Drug Development Services), an affiliate of The Translational Genomics Research Institute (TGen) have found ImmuneRegen's Radilex (TM) to protect mice from the near total destruction of circulating white blood cells following radiation exposure. These findings support past data and provide further insight into possible mechanisms underlying the activity of Radilex as well as suggest possible therapeutic areas in which Radilex could play a role as a potential treatment.

In previous studies of lethally irradiated mice, Radilex was shown to enhance survival and increase white blood cells in surviving animals. In the recent studies, a sub-lethal dose of radiation induced a 90-95% decrease in circulating white blood cell levels. Administered shortly following radiation exposure, Radilex was able to subsequently increase circulating levels of monocytes, granulocytes and lymphocytes in all treated animals.

"The results of this study have strengthened our confidence that Radilex(TM) may prove to be a life saving treatment candidate as well as a drug and treatment enhancement candidate," says Michael K. Wilhelm, Co-Founder and CEO of ImmuneRegen BioSciences, Inc. "We are very happy that our relationship with TGen continues to develop a promising collection of data on Radilex's ability to potentially preserve human life after lethal or sub-lethal exposure to radiation."

Low circulating white blood cell counts (leukopenia or leukocytopenia) can be due to a number of causes, among them infections (including certain viral infections such as
'/>"/>

SOURCE ImmuneRegen BioSciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent
2. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
5. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
6. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
7. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
8. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
9. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
10. Cipralex demonstrates superiority to duloxetine for acute treatment of depression in new study
11. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., MINNEAPOLIS, Nov. 20 ...results for its first quarter ended September 30, ...iluted share, on revenues of $3,263,000. This com...luted share, on revenues of $3,168,000 for the fir...irst quarter results, Biotel President and CEO Ste...
(Date:11/20/2009)..., FRANKLIN LAKES, N.J., Nov. 20 /PRNewswire-Fir...E: BDX ) today announced the completion of its a...an-based company that develops and manufactures mo.... ,, In May 2009, BD and HandyLab announced an ...alize molecular assays on the HandyLab Jaguar(TM) ...
(Date:11/19/2009)... , ARDEE, Ireland, Nov. 19 Warn...he pricing of its previously announced secondary o...price to the public of $22.25 per share. The sell...n Capital Partners, DLJ Merchant Banking, J.P. Mor...H. Lee Partners, L.P., certain other institutional...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4Growing Supply Chain Complexity Increasing Impact on Medical Device Company Operations 5442 1Growing Supply Chain Complexity Increasing Impact on Medical Device Company Operations 5442 2Growing Supply Chain Complexity Increasing Impact on Medical Device Company Operations 5442 3BIOSAFE Launching In a New Specially Treated Facemask Effective Against H1N1 Influenza 5438 1BIOSAFE Launching In a New Specially Treated Facemask Effective Against H1N1 Influenza 5438 2BIOSAFE Launching In a New Specially Treated Facemask Effective Against H1N1 Influenza 5438 3BIOSAFE Launching In a New Specially Treated Facemask Effective Against H1N1 Influenza 5438 4Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR 28R 29 5434 1Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR 28R 29 5434 2Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR 28R 29 5434 3
...CO, Calif., March 26 Poniard,Pharmaceuticals, Inc...cused,on oncology, announced an agreement with W. ... supply of picoplatin active pharmaceutical,ingred...he Company,s lead,product candidate, in four clini...trial in small cell lung cancer, and is developing...
...ts collaborate with UBC to provide best science av...s cutting-edge,thinking in study methodology for C...UBC) announces the formation of a European Advisor...established to support UBC in its,ongoing efforts ... that,rely on subjective measurements as pivotal e...
Other Medicine Technology:Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin 2Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin 3UBC Forms European Advisory Board to Enhance Data Quality of CNS Trials 2UBC Forms European Advisory Board to Enhance Data Quality of CNS Trials 3
(Date:11/21/2009)... Group ask whether there is a secret to ,alcohol r... London, UK (PRWEB) November 21, 200...hree of the adult UK population drinking enough al...ed liver disease*, it is hardly a surprise that ma...rammes and residential centres for help. However, ...
(Date:11/20/2009)... The American Academy o... care reform legislation released this week to con...e individual coverage mandate. The actuaries said ...imize adverse selection stemming from more restric.... ,, "The individual mandate language should be...
(Date:11/20/2009)...s and Congressmen in Competitive Re-election Battl... , Washington, DC (Vocus)...ning for re-election next year in races deemed to ... come to regret voting for House Speaker Nancy Pel...ing Zogby International/ O’Leary Report pol...
(Date:11/20/2009)... Centene Corporation (N...at the Bank of America Merrill Lynch 2009 Credit C...rowne Plaza Hotel Times Square in New York City. ,...at 8:30 a.m. Eastern Time. Investors and other int...f Centene,s presentation at: http://www.veracast....
(Date:11/20/2009)...ewswire-USNewswire/ -- The following is a statemen...da Health Care Association: ,, "The Nevada Heal...ate Majority Leader Harry Reid for his leadership ... of protecting every Nevada seniors, ongoing acces... strength and viability of our state,s vital front...
Breaking Medicine News(10 mins):Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3
...egina is a volunteer of Médecins sans Frontières (... patients in the area take their medication regula...sease. The chief difficulty // for those who are ...a patient has to consume. Volunteers help t...
...mericans consume far too much sodium, putting them...d stroke, according to a new study published in th...ive Medicine. // Although people who already... levels, according to lead researcher Umed Ajani, ...
...r Adam Gibson and his research team are all set to...IR). This brain scanner provides an insight ab... it etc. // It was developed by University College...xecute brain scans on babies. One is the usage o...
...esearchers at the Bassett Research Institute of th...w York and The Thomas Jefferson University in Phil...cancer in laboratory mice was // stimulated by the...th Sciences, also found that the tumors were stimu...
...f smoking were to be banned by the Government in b...e will be affected by passive smoking. Children su...ficulties due to passive smoking. The economists b...o quit as a result of a total ban, according to th...
...he risk of a degenerative eye disease is raised du...of the eye degenerates with higher levels of smoki...ading which require fine central vision. About 435...s the amount smoked rather than whether someone ha...
Other Medicine News:Health News:Americans Consume Far Too Much Salt and Sodium 2Health News:Detecting Brain Abnormalities in Babies Using New Brain Scanners. 2Health News:Artificial Light Stimulates Breast Cancer Growth In Mice: Study 2
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: